TY - JOUR
T1 - Extended-spectrum β-lactamase-producing Enterobacteriaceae colonisation in long-term care facilities
T2 - a systematic review and meta-analysis
AU - Flokas, Myrto Eleni
AU - Alevizakos, Michail
AU - Shehadeh, Fadi
AU - Andreatos, Nikolaos
AU - Mylonakis, Eleftherios
N1 - Publisher Copyright:
© 2017 Elsevier B.V. and International Society of Chemotherapy
PY - 2017/11
Y1 - 2017/11
N2 - The objectives of this study were to estimate the colonisation rate by extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-PE) among residents of long-term care facilities (LTCFs) and to identify pertinent risk factors. A systematic search of PubMed and EMBASE databases for studies published up to May 2016 that provided raw data for gastrointestinal colonisation by ESBL-PE among LTCF residents was performed. Twenty-three studies reporting data on 9775 screened subjects met the inclusion criteria. The pooled prevalence of ESBL-PE among LTCF residents was 18% [95% confidence interval (CI) 12–24%]. Risk factors for colonisation included recent antibiotic use (within 6 months) [odds ratio (OR) = 2.06, 95% CI 1.78–2.38], previous hospitalisation (within 2.5 years) (OR = 1.50, 95% CI 1.04–2.15), history of invasive procedures (within 2 years) (OR = 2.79, 95% CI 1.66–4.70), previous ESBL-PE colonisation or infection (OR = 6.77, 95% CI 1.33–34.62), history of urinary tract infection (OR = 2.66, 95% CI 1.76–4.01) and urinary catheter use (OR = 2.55, 95% CI 1.29–5.04). In conclusion, almost one in five LTCF residents is colonised with ESBL-PE, and colonised residents are more likely to have a history of recent antibiotic use or healthcare facility utilisation. Strict adherence to antimicrobial stewardship in LTCFs is needed to address these high resistance rates.
AB - The objectives of this study were to estimate the colonisation rate by extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-PE) among residents of long-term care facilities (LTCFs) and to identify pertinent risk factors. A systematic search of PubMed and EMBASE databases for studies published up to May 2016 that provided raw data for gastrointestinal colonisation by ESBL-PE among LTCF residents was performed. Twenty-three studies reporting data on 9775 screened subjects met the inclusion criteria. The pooled prevalence of ESBL-PE among LTCF residents was 18% [95% confidence interval (CI) 12–24%]. Risk factors for colonisation included recent antibiotic use (within 6 months) [odds ratio (OR) = 2.06, 95% CI 1.78–2.38], previous hospitalisation (within 2.5 years) (OR = 1.50, 95% CI 1.04–2.15), history of invasive procedures (within 2 years) (OR = 2.79, 95% CI 1.66–4.70), previous ESBL-PE colonisation or infection (OR = 6.77, 95% CI 1.33–34.62), history of urinary tract infection (OR = 2.66, 95% CI 1.76–4.01) and urinary catheter use (OR = 2.55, 95% CI 1.29–5.04). In conclusion, almost one in five LTCF residents is colonised with ESBL-PE, and colonised residents are more likely to have a history of recent antibiotic use or healthcare facility utilisation. Strict adherence to antimicrobial stewardship in LTCFs is needed to address these high resistance rates.
KW - Colonisation
KW - Extended-spectrum β-lactamase
KW - Long-term care facilities
KW - Nursing homes
UR - http://www.scopus.com/inward/record.url?scp=85032428662&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85032428662&partnerID=8YFLogxK
U2 - 10.1016/j.ijantimicag.2017.08.003
DO - 10.1016/j.ijantimicag.2017.08.003
M3 - Review article
C2 - 28782707
AN - SCOPUS:85032428662
VL - 50
SP - 649
EP - 656
JO - International Journal of Antimicrobial Agents
JF - International Journal of Antimicrobial Agents
SN - 0924-8579
IS - 5
ER -